-
5541
-
5542
-
5543
Global research trends in Chinese medicine for the treatment of non-alcoholic fatty liver disease (NAFLD): A bibliometric study
Published 2025-03-01“…The top 10 key journals account for 49.02 % of the publications, with Frontiers in Pharmacology being the most prolific, while the World Journal of Gastroenterology boasts the highest average number of citations. …”
Get full text
Article -
5544
Project-based management to reduce skin damage associated with acupressure medical adhesives in patients undergoing acupoint application for chronic gastritis (基于项目化管理降低慢性胃炎患者穴位贴敷医...
Published 2024-05-01“…Finally, 235 cases of chronic gastritis were selected from the Department of Gastroenterology from October 2021 to March 2022 as the intervention group (2215 times of application) for project management; From October 2020 to March 2021, 235 patients with chronic gastritis were used as the control group (2215 times of application) and were managed by traditional mode, comparing the quality management results of the specific work, associated skin damage, and pain scores at removal of the acupressure applied in both groups. …”
Get full text
Article -
5545
-
5546
-
5547
-
5548
-
5549
-
5550
-
5551
-
5552
Epithelial NSD2 maintains FMO‐mediated taurine biosynthesis to prevent intestinal barrier disruption
Published 2024-12-01Get full text
Article -
5553
-
5554
-
5555
-
5556
-
5557
-
5558
-
5559
-
5560
Paucity of viral infection symptoms in patients with immune-mediated inflammatory diseases
Published 2025-01-01“…This study aimed to investigate the symptom pattern of common viral infections in patients with IMID and compare it with controls without IMIDs.Design A cross-sectional study conducted between 1 February and 30 April 2020, using a questionnaire.Setting Seven tertiary regional care centers in Germany, which specialised in the care of patients with IMID (namely, in gastroenterology, dermatology, rheumatology and immunology clinical care).Participants One thousand nine hundred nine participants completed the survey (757 patients with IMID; 1152 non-IMID controls).Primary outcome measure The occurrence of 11 common viral illness symptoms within the preceding 3 months in patients with IMID and non-IMID controls.Results Symptom data were clustered, based on number and co-occurrance, into 3 major clusters and 2 subclusters ranked by the average number of symptoms. …”
Get full text
Article